US EditionPublished • loading... • Updated
Trump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies
Nine pharmaceutical firms agreed to lower U.S. drug prices to align with other developed nations under the Trump administration’s Most Favored Nation policy, promising billions in savings.
- On Friday, President Donald Trump announced agreements with nine pharmaceutical groups to lower U.S. drug prices in exchange for tariff relief under the most-favoured-nation pricing policy.
- In July the administration pressed most-favoured-nation pricing to align U.S. drug costs with price-controlled countries and pressured several previously negotiating firms including Pfizer, AstraZeneca, Eli Lilly, Novo Nordisk, EMD Serono.
- Selected drugs including Amgen's Repatha, BMS' Reyataz, Sanofi's Plavix, and Novartis' Mayzent will be offered through the TrumpRx direct-to-consumer channel at discounts up to 70%.
- The White House said the agreements will yield billions of dollars in savings, while Democrats and lawmakers pressed AstraZeneca, Eli Lilly, Novo Nordisk, and Pfizer for transparency last week.
- Wall Street analysts say the new deals will have negligible effects on sales and profits, with Johnson & Johnson, AbbVie and Regeneron expected to join soon.
Insights by Ground AI
17 Articles
17 Articles
Most people have insurance through work, the individual insurance market, or government programs like Medicaid and Medicare, which protect them from much of the cost.
·Los Angeles, United States
Read Full Article
MedPage TodayReposted by 
Anti-Aging, Acupuncture and Health News
Anti-Aging, Acupuncture and Health NewsTrump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies
(MedPage Today) -- President Trump announced on Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences...
·New York, United States
Read Full Article
Coverage Details
Total News Sources17
Leaning Left1Leaning Right4Center6Last UpdatedBias Distribution55% Center
Bias Distribution
- 55% of the sources are Center
55% Center
C 55%
R 36%
Factuality
To view factuality data please Upgrade to Premium
